Drug & Alcohol Rehabilitation Clinics in the US - Industry Market Research Report

Clean and Clear: New Treatment Methods May Shift Patients Away from Specialized Industry Clinics

Rising awareness of the importance of substance abuse treatment has supported drug and alcohol rehabilitation clinics in recent years. Medicare and Medicaid coverage expansion and program funding through SAMHSA have aligned with the changing societal attitudes toward drug and alcohol abuse. Expansion of clinics has been vital, as rising rates of substance abuse and a worsening opioid epidemic expand the need for accessible treatment. COVID-19 exacerbated preexisting rates of substance abuse in the US. Long periods of stress and isolation pushed many people to drugs and alcohol to cope, while the CDC is attributing the increasing use of fentanyl to an unprecedented overdose death rate. Pandemic-related operating and labor challenges have strained clinics' ability to meet the record-high demand. Despite this, rising incomes, broader insurance coverage and changing attitudes have led industry-wide revenue to expand at a CAGR of 3.3% over the past five years, totaling an estimated $5.0 billion in 2023, when revenue is slated to increase 1.5%.

The Drug and Alcohol Rehabilitation Clinics industry comprises clinics with medical staff that primarily provide inpatient and outpatient services related to diagnosing and treating alcohol, drug and other substance abuse. For-profit and nonprofit establishments are included.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry's key players and their market shares.